A slide from the Exalgo Alliance website. It is titled "Patient Selection" and has a title at the top that reads "Appropriate patients for once-daily EXALGO must: - be opioid tolerant - have moderate to severe pain - require continuous around-the-clock analgesia". Below the title there is a description of the patient selection which states that the patient contains hydromorphone a Schedule II controlled substance which can be abused and diverted.
The slide also mentions that all patients should be screened for and stratified according to their risk factors for abuse and diversion. All patients treated with EXALGO require careful monitoring for signs of abuse.
At the bottom of the slide there are two bullet points that explain the patient's full prescribing information.
Description 
Type
Category
-
Date
2009
Collection
We encourage you to view the image in the context of its source document(s) and cite the source(s) when using these images. However, to cite just this image alone, click the “Cite This Image” button and then paste the copied text.
